← Leaderboards
Debra L Friedman
Vanderbilt University Medical Center
$19,684,821
Attributed
$38,121,045
Total exposure
28
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,727,975 · 29
By mechanism
K12$9,797,946 · 1
R01$9,725,578 · 4
UH3$6,381,605 · 1
U01$4,065,243 · 1
UG3$2,127,132 · 1
U54$1,656,316 · 2
Top collaborators
- Tuya Pal11 shared
- Joseph P Neglia6 shared
- Wendy K Rathmell6 shared
- Michael Rutledge Debaun5 shared
- Courtney D Fitzhugh5 shared
- Ben H Park5 shared
- Xiao-Ou Shu5 shared
- Kenneth R. Hande4 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Michael Rutledge Debaun$40,846,229
- Anthony Brent Daniels$1,134,059
- Courtney D Fitzhugh$1,016,311
- Natasha Bassam Halasa$37,609,939
- Sapna S Gangaputra$1,448,399
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsDesignProgramsResearch PersonnelIncidenceCancer CenterCancer TherapyInstitutionSurvivorshipFundingMortalityBaseOncologyAreaAdultCancer CareFacultyCommunitiesUnited StatesSurvivorsPediatric OncologyPsychosocialClinical ResearchCohort
Grant awards (96)
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan$2,201,003
UH3 · FY2025 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$953,460
K12 · FY2025 · CA · contact PI
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease$841,945
U01 · FY2025 · HL
Core 1: PRACTICE Shared Resource Core$347,315
U54 · FY2025 · CA · contact PI
VOLT (Vanderbilt Oncology Training Program)$303,759
T32 · FY2025 · CA
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan$2,243,832
UH3 · FY2024 · CA · contact PI
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease$827,619
U01 · FY2024 · HL
Vanderbilt Clinical Oncology Research Career Development Award$702,458
K12 · FY2024 · CA · contact PI
Core 1: PRACTICE Shared Resource Core$353,699
U54 · FY2024 · CA · contact PI
VOLT (Vanderbilt Oncology Training Program)$322,587
T32 · FY2024 · CA
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan$1,936,770
UH3 · FY2023 · CA · contact PI
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease$849,699
U01 · FY2023 · HL
Vanderbilt Clinical Oncology Research Career Development Award$807,932
K12 · FY2023 · CA · contact PI
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)$622,074
R01 · FY2023 · CA · contact PI
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium$497,944
R01 · FY2023 · CA · contact PI
VOLT (Vanderbilt Oncology Training Program)$357,855
T32 · FY2023 · CA
Core 1: PRACTICE Shared Resource Core$340,367
U54 · FY2023 · CA · contact PI
Community Outreach and Engagement$255,402
P30 · FY2023 · CA · contact PI
Cancer Health Outcomes and Control Research Program$124,453
P30 · FY2023 · CA · contact PI
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan$1,050,989
UG3 · FY2022 · CA · contact PI
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease$854,865
U01 · FY2022 · HL
Vanderbilt Clinical Oncology Research Career Development Award$795,679
K12 · FY2022 · CA
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)$631,185
R01 · FY2022 · CA · contact PI
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium$495,029
R01 · FY2022 · CA · contact PI
Core 1: PRACTICE Shared Resource Core$283,649
U54 · FY2022 · CA · contact PI
Community Outreach and Engagement$255,402
P30 · FY2022 · CA · contact PI
Cancer Health Outcomes and Control Research Program$124,453
P30 · FY2022 · CA · contact PI
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan$1,076,143
UG3 · FY2021 · CA · contact PI
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease$691,115
U01 · FY2021 · HL
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)$657,837
R01 · FY2021 · CA · contact PI
Core 1: PRACTICE Shared Resource Core$331,286
U54 · FY2021 · CA · contact PI
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium$169,382
R01 · FY2021 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$934,031
K12 · FY2020 · CA
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)$863,700
R01 · FY2020 · CA · contact PI
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium$603,190
R01 · FY2020 · CA · contact PI
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)$150,000
R01 · FY2020 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$919,030
K12 · FY2019 · CA
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)$691,805
R01 · FY2019 · CA · contact PI
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium$658,729
R01 · FY2019 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$961,183
K12 · FY2018 · CA
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium$771,034
R01 · FY2018 · CA · contact PI
Cancer Health Outcomes and Control Research Program (CO) (Project-007)$87,030
P30 · FY2018 · CA · contact PI
Cancer Health Outcomes and Control Research Program (CO) (Project-007)$9,999
P30 · FY2018 · CA · contact PI
Cancer Health Outcomes and Control Research Program (CO) (Project-007)$7,996
P30 · FY2018 · CA · contact PI
Cancer Health Outcomes and Control Research Program (CO) (Project-007)$7,968
P30 · FY2018 · CA · contact PI
Cancer Health Outcomes and Control Research Program (CO) (Project-007)$4,817
P30 · FY2018 · CA · contact PI
Cancer Health Outcomes and Control Research Program (CO) (Project-007)$4,734
P30 · FY2018 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$800,773
K12 · FY2017 · CA
Cancer Health Outcomes and Control Research Program (CO) (Project-007)$87,030
P30 · FY2017 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$454,075
K12 · FY2016 · CA
Cancer Health Outcomes and Control Research Program (CO) (Project-007)$84,561
P30 · FY2016 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$309,351
K12 · FY2015 · CA
Vanderbilt Clinical Oncology Research Career Development Award$209,064
K12 · FY2015 · CA
Conducting Research in Pediatric Hematology/Oncology$133,570
T32 · FY2015 · CA · contact PI
Cancer Health Outcomes and Control Research Program (CO) (Project-007)$84,561
P30 · FY2015 · CA · contact PI
Cancer Health Outcomes and Control Research Program (CO) (Project-007)$48,838
P30 · FY2015 · CA · contact PI
Conducting Research in Pediatric Hematology/Oncology$21,600
T32 · FY2015 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$1,007,108
K12 · FY2014 · CA
Conducting Research in Pediatric Hematology/Oncology$146,593
T32 · FY2014 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$943,802
K12 · FY2013 · CA
Conducting Research in Pediatric Hematology/Oncology$137,872
T32 · FY2013 · CA · contact PI
MMC and VICC: Partnering for Survivorship (2)$122,186
P20 · FY2013 · CA · contact PI
Initial Planning$68,198
P20 · FY2013 · CA · contact PI
Implementation Pilot 3$27,689
P20 · FY2013 · CA · contact PI
Telephone Counseling - Caregivers for Children with Cancer$208,772
R21 · FY2012 · CA · contact PI
Conducting Research in Pediatric Hematology/Oncology$149,612
T32 · FY2012 · CA · contact PI
MMC and VICC: Partnering for Survivorship (2)$145,404
P20 · FY2012 · CA · contact PI
Initial Planning$85,743
P20 · FY2012 · CA · contact PI
Telephone Counseling - Caregivers for Children with Cancer$208,651
R21 · FY2011 · CA · contact PI
MMC and VICC: Partnering for Survivorship (2)$167,486
P20 · FY2011 · CA · contact PI
Initial Planning$82,240
P20 · FY2011 · CA · contact PI
Conducting Research in Pediatric Hematology/Oncology$78,370
T32 · FY2011 · CA · contact PI
Implementation Pilot 3$1
P20 · FY2011 · CA · contact PI
MMC and VICC: Partnering for Survivorship (2)$171,854
P20 · FY2010 · CA · contact PI
Initial Planning$95,165
P20 · FY2010 · CA · contact PI
Implementation Pilot 3$1
P20 · FY2010 · CA · contact PI
Radiation Sensitivity, DNA Repair and Second Cancers$290,475
R01 · FY2008 · CA · contact PI
Health Outcomes for Hodgkin Disease Survivors$295,264
R01 · FY2007 · CA · contact PI
Radiation Sensitivity, DNA Repair and Second Cancers$254,400
R01 · FY2007 · CA · contact PI
Health Outcomes for Hodgkin Disease Survivors$99,859
R01 · FY2007 · CA · contact PI
EXERCISE AND FITNESS IN CHILDHOOD CANCER SURVIVORS$4,188
M01 · FY2007 · RR · contact PI
EXERCISE AND FITNESS IN CHILDHOOD CANCER SURVIVORS$1,900
M01 · FY2007 · RR · contact PI
SOCIAL & PHYSICAL ACTIVITY OF CHILDHOOD CANCER SURVIVORS$1,068
M01 · FY2007 · RR · contact PI
Health Outcomes for Hodgkin Disease Survivors$373,418
R01 · FY2006 · CA · contact PI
Radiation Sensitivity, DNA Repair and Second Cancers$261,998
R01 · FY2006 · CA · contact PI
Social & Physical Activity of Childhood Cancer Survivors$172,572
R21 · FY2006 · CA · contact PI
EXERCISE AND FITNESS IN CHILDHOOD CANCER SURVIVORS$23,155
M01 · FY2006 · RR · contact PI
EXERCISE AND FITNESS IN CHILDHOOD CANCER SURVIVORS$6,617
M01 · FY2006 · RR · contact PI
Health Outcomes for Hodgkin Disease Survivors$327,618
R01 · FY2005 · CA
Radiation Sensitivity, DNA Repair and Second Cancers$268,304
R01 · FY2005 · CA
Social &Physical Activity of Childhood Cancer Survivors$185,975
R21 · FY2005 · CA
Exercise and Fitness in Childhood Cancer Survivors$107,651
R21 · FY2005 · CA
Health Outcomes for Hodgkin Disease Survivors$455,779
R01 · FY2004 · CA
Radiation Sensitivity, DNA Repair and Second Cancers$286,554
R01 · FY2004 · CA
Exercise and Fitness in Childhood Cancer Survivors$117,357
R21 · FY2004 · CA
Drug Metabolism, DNA Repair &Second Cancers$131,220
K07 · FY2003 · CA